Wall Street Journal: The human and physical logistics behind COVID vaccine rollouts
UC emergency medicine expert shares insight on how COVID-19 vaccines will be distributed
As states and hospitals in the United States race to roll out the first COVID-19 vaccines, the Wall Street Journal talked to a hospital administrator and immunization expert about the logistical challenges involved in this first phase of the vaccination process.
Dustin Calhoun, MD, of the Department of Emergency Medicine at the UC College of Medicine. Photo/Colleen Kelley/ UC Creative + Brand
University of Cincinnati Medical Center will be one of the locations distributing the Pfizer COVID-19 vaccine. Dustin Calhoun, MD, in the Department of Emergency Medicine at the UC College of Medicine, says in Ohio, the vaccine will be distributed in lots of 975 doses.
"The prepositioning sites will probably be receiving one package each initially, and then significantly larger amounts flowing after that," says Calhoun. "Any facility that needs a smaller amount than the 975 of the Pfizer vaccine, will be receiving it after it is re-processed through the state of Ohio into smaller lots of about 100 doses."
Calhoun says the initial rollout of the vaccine to frontline health care workers will help guide the process of giving it to the general population once the vaccine is more widely available.
Watch the full video report here.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
German TV highlights UC expert's ancient Maya discoveries
March 2, 2026
The German television show 'Unsolved Case' talks to a University of Cincinnati expert about ballcourts used by the ancient Maya for a program examining how people used spheres as both tools and toys.
UC studies supplement, therapy alternatives to treat depression
March 2, 2026
Media outlets including Cleveland.com and Cleveland's WKYC News highlighted a new University of Cincinnati clinical trial funded by an approximately $3.5 million grant from the National Institutes of Health’s National Center for Complementary and Integrative Health to test two new nonpharmacological treatments for teens and young adults with depression.
'Paradigm-shifting' study confirms effectiveness of long-acting HIV treatment
February 26, 2026
The results of a clinical trial involving the University of Cincinnati, recently published in The New England Journal of Medicine, show people failing HIV treatments with oral medications were able to be treated successfully using injections.